178 related articles for article (PubMed ID: 16984497)
1. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study.
Grudell AB; Camilleri M; Burton DD; Stephens DA
Aliment Pharmacol Ther; 2006 Oct; 24(7):1037-43. PubMed ID: 16984497
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
[TBL] [Abstract][Full Text] [Related]
3. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions.
Cremonini F; Camilleri M; Vazquez Roque M; McKinzie S; Burton D; Baxter K; Zinsmeister AR
Gastroenterology; 2006 Nov; 131(5):1431-9. PubMed ID: 17101319
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
[TBL] [Abstract][Full Text] [Related]
5. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
[TBL] [Abstract][Full Text] [Related]
6. Effect of somatostatin analog on postprandial satiation in obesity.
Cremonini F; Camilleri M; Gonenne J; Stephens D; Oenning L; Baxter K; Foxx-Orenstein A; Burton D
Obes Res; 2005 Sep; 13(9):1572-9. PubMed ID: 16222060
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.
Kim DY; Delgado-Aros S; Camilleri M; Samsom M; Murray JA; O'Connor MK; Brinkmann BH; Stephens DA; Lighvani SS; Burton DD
Am J Gastroenterol; 2001 Nov; 96(11):3099-105. PubMed ID: 11721755
[TBL] [Abstract][Full Text] [Related]
8. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
[TBL] [Abstract][Full Text] [Related]
9. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.
Farré R; Vanheel H; Vanuytsel T; Masaoka T; Törnblom H; Simrén M; Van Oudenhove L; Tack JF
Gastroenterology; 2013 Sep; 145(3):566-73. PubMed ID: 23702005
[TBL] [Abstract][Full Text] [Related]
10. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
Arts J; Caenepeel P; Verbeke K; Tack J
Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans.
Kuo B; Camilleri M; Burton D; Viramontes B; McKinzie S; Thomforde G; O'Connor MK; Brinkmann BH
Aliment Pharmacol Ther; 2002 Feb; 16(2):225-33. PubMed ID: 11860405
[TBL] [Abstract][Full Text] [Related]
14. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study.
Delgado-Aros S; Camilleri M; Castillo EJ; Cremonini F; Stephens D; Ferber I; Baxter K; Burton D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2005 Oct; 3(10):997-1006. PubMed ID: 16234046
[TBL] [Abstract][Full Text] [Related]
15. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man.
Ang D; Nicolai H; Vos R; Mimidis K; Akyuz F; Kindt S; Vanden Berghe P; Sifrim D; Depoortere I; Peeters T; Tack J
Neurogastroenterol Motil; 2009 May; 21(5):528-33, e8-9. PubMed ID: 19210631
[TBL] [Abstract][Full Text] [Related]
16. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia.
Chitkara DK; Camilleri M; Zinsmeister AR; Burton D; El-Youssef M; Freese D; Walker L; Stephens D
J Pediatr; 2005 Apr; 146(4):500-5. PubMed ID: 15812453
[TBL] [Abstract][Full Text] [Related]
17. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
[TBL] [Abstract][Full Text] [Related]
18. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.
Delgado-Aros S; Kim DY; Burton DD; Thomforde GM; Stephens D; Brinkmann BH; Vella A; Camilleri M
Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G424-31. PubMed ID: 11841992
[TBL] [Abstract][Full Text] [Related]
19. Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial.
Brandler J; Miller LJ; Wang XJ; Burton D; Busciglio I; Arndt K; Harmsen WS; Camilleri M
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G635-G645. PubMed ID: 32036693
[TBL] [Abstract][Full Text] [Related]
20. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
